These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

656 related items for PubMed ID: 15665028

  • 1. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjöquist M.
    Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
    [Abstract] [Full Text] [Related]

  • 2. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
    Samnegård B, Jacobson SH, Johansson BL, Ekberg K, Isaksson B, Wahren J, Sjöquist M.
    Nephrol Dial Transplant; 2004 Jun; 19(6):1385-91. PubMed ID: 15004258
    [Abstract] [Full Text] [Related]

  • 3. Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.
    Bach LA, Cooper ME, Vranes D, Allen TJ, Rumble J, Jerums G.
    Diabetes Res; 1994 Jun; 27(1):27-38. PubMed ID: 7648794
    [Abstract] [Full Text] [Related]

  • 4. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats.
    Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Sjöquist M.
    Kidney Int; 2001 Oct; 60(4):1258-65. PubMed ID: 11576340
    [Abstract] [Full Text] [Related]

  • 5. The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin-induced diabetic rats.
    Nordquist L, Moe E, Sjöquist M.
    Diabetes Metab Res Rev; 2007 Jul; 23(5):400-5. PubMed ID: 17103462
    [Abstract] [Full Text] [Related]

  • 6. Effect of aspirin on experimental diabetic nephropathy.
    Moel DI, Safirstein RL, McEvoy RC, Hsueh W.
    J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
    [Abstract] [Full Text] [Related]

  • 7. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
    Sassy-Prigent C, Heudes D, Jouquey S, Auberval D, Belair MF, Michel O, Hamon G, Bariety J, Bruneval P.
    Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effects of C-peptide on renal morphology in diabetic rats.
    Sun W, Gao X, Zhao X, Cui D, Xia Q.
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec; 42(12):893-9. PubMed ID: 21106770
    [Abstract] [Full Text] [Related]

  • 9. Rapamycin prevents early steps of the development of diabetic nephropathy in rats.
    Yang Y, Wang J, Qin L, Shou Z, Zhao J, Wang H, Chen Y, Chen J.
    Am J Nephrol; 2007 Dec; 27(5):495-502. PubMed ID: 17671379
    [Abstract] [Full Text] [Related]

  • 10. Influence of C-peptide on early glomerular changes in diabetic mice.
    Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H, Tokuyama T, Takemoto M, Ueda S, Kuwaki T, Mori S, Wahren J, Saito Y.
    Diabetes Metab Res Rev; 2006 Dec; 22(4):313-22. PubMed ID: 16389646
    [Abstract] [Full Text] [Related]

  • 11. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy.
    Mima A, Arai H, Matsubara T, Abe H, Nagai K, Tamura Y, Torikoshi K, Araki M, Kanamori H, Takahashi T, Tominaga T, Matsuura M, Iehara N, Fukatsu A, Kita T, Doi T.
    Diabetes; 2008 Jun; 57(6):1712-22. PubMed ID: 18285555
    [Abstract] [Full Text] [Related]

  • 12. Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study.
    Huang DY, Richter K, Breidenbach A, Vallon V.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):67-73. PubMed ID: 11862335
    [Abstract] [Full Text] [Related]

  • 13. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of C-peptide on renal function at the early stage of experimental diabetes.
    Sjöquist M, Huang W, Johansson BL.
    Kidney Int; 1998 Sep 20; 54(3):758-64. PubMed ID: 9734600
    [Abstract] [Full Text] [Related]

  • 20. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats.
    Kamikawa A, Ishii T, Shimada K, Makondo K, Inanami O, Sakane N, Yoshida T, Saito M, Kimura K.
    Diabetes Metab Res Rev; 2008 Sep 20; 24(4):331-8. PubMed ID: 18088079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.